GlassScriptPhysician profile
David A Cusick
NPI 1093779647
$16,430.59
in general payments reported to CMS, 2019-2025
48 companies · $2,132 in 2025
The $2,132 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,508 · 2020: $1,758 · 2021: $3,420 · 2022: $2,883 · 2023: $1,910 · 2024: $1,820 · 2025: $2,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,861.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,368.62 | 2019-2025 | |
| Pfizer INC. | $1,651.08 | 2019-2025 | |
| Amgen INC. | $1,397.76 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,172.59 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,051.49 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $974.20 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $817.93 | 2019-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $690.46 | 2021-2025 | Verquvo |
| Esperion Therapeutics, INC. | $628.95 | 2020-2025 | Nexletol |
| Boston Scientific Corporation | $580.05 | 2019-2024 | Watchman Access System, Bodyguardian |
| Boehringer Ingelheim Pharmaceuticals, INC. | $556.45 | 2019-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $555.39 | 2022-2025 | Assure Wcd |
| Amarin Pharma, INC. | $497.00 | 2019-2022 | |
| Preventric Diagnostics, INC. | $464.50 | 2021 | |
| Sanofi-Aventis U.S. LLC | $452.05 | 2019-2024 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $203.69 | 2019-2022 | |
| Medtronic, INC. | $195.09 | 2023 | Corevalve Evolut R, Symplicity G3 |
| Alnylam Pharmaceuticals INC. | $177.12 | 2023-2025 | Onpattro, Amvuttra |
| Idorsia Pharmaceuticals US INC | $173.27 | 2025 | Tryvio |
| Jenavalve Technology, INC. | $162.44 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $146.58 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $145.74 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $141.24 | 2019-2023 | Amplatzer Amulet |
| Kiniksa Pharmaceuticals, LTD. | $130.23 | 2022-2023 | Arcalyst |
| Cleerly, INC. | $115.99 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Scpharmaceuticals INC. | $112.11 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.90 | 2021-2025 | |
| Chiesi USA, INC. | $95.76 | 2020-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $70.63 | 2024 | Arcalyst |
| Vital Connect, INC | $63.44 | 2025 | Vitalpatch Rtm |
| Edwards Lifesciences Corporation | $63.11 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $57.28 | 2022-2025 | Opsumit, Uptravi |
| Ge Healthcare | $51.59 | 2025 | |
| Masimo Corporation | $51.23 | 2022-2023 | Set and Rainbow Set |
| Lantheus Medical Imaging, INC. | $37.57 | 2019-2025 | |
| Amryt Pharma Holdings LTD | $32.61 | 2022 | |
| Tactile Systems Technology INC | $31.29 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $30.80 | 2020-2021 | |
| Siemens Medical Solutions USA, INC. | $26.95 | 2025 | |
| Daiichi Sankyo INC. | $25.41 | 2023 | Injectafer |
| Lundbeck LLC | $24.88 | 2019 | |
| Inspire Medical Systems, INC. | $18.97 | 2023 | Inspire |
| Elutia, INC. | $16.96 | 2022 | |
| Philips North America LLC | $16.96 | 2020 | |
| Medtronic Vascular, INC. | $15.75 | 2020 | |
| Baxter Healthcare | $14.62 | 2024 | Biopharma Sol - Contract Manuf |
| Arbor Pharmaceuticals, INC. | $13.70 | 2020 | |
| Biotronik INC. | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cusick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.